#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15482	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2171	705.2	0	.	n	.	0	C451T	SNP	451	451	C	682	682	T	872	T,C	829,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15482	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2171	705.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	914	C	870	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27836	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3545	779.2	0	.	n	.	0	T695C	SNP	695	695	T	1030	1030	C	805	C,T,G	764,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27836	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3545	779.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2306	2306	C	937	C	871	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27836	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3545	779.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2380	2380	A	911	A	868	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27836	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3545	779.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2932	2932	C	866	C	821	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27836	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3545	779.2	0	HET	.	.	.	A1638G	.	1638	1638	A	1973	1973	A	887	A,G	671,177	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27836	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3545	779.2	0	HET	.	.	.	G2616A	.	2616	2616	G	2951	2951	G	867	G,A	659,165	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2062	folP	855	855	100.0	folP.l6.c4.ctg.1	1430	142.5	1	SNP	p	R229S	1	.	.	685	687	AGC	962	964	AGC	208;209;210	A;G;C	196;197;196	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5510	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3322	164.7	1	SNP	p	S91F	1	.	.	271	273	TTC	498	500	TTC	180;178;178	T;T;C	168;169;169	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5510	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3322	164.7	1	SNP	p	D95G	1	.	.	283	285	GGC	510	512	GGC	186;184;184	G;G,A;C	174;169,1;170	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5510	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3322	164.7	1	SNP	p	G95N	0	.	.	283	285	GGC	510	512	GGC	186;184;184	G;G,A;C	174;169,1;170	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1784	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1306	136.0	1	SNP	p	G45D	0	.	.	133	135	GGC	445	447	GGC	227;230;228	G;G;C	215;213;213	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	960	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	978	97.4	0	.	n	.	0	A197.	DEL	197	197	A	614	614	A	197	A	191	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5260	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2893	180.2	1	SNP	p	D86N	0	.	.	256	258	GAC	617	619	GAC	206;206;207	G;A;C	197;190;198	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5260	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2893	180.2	1	SNP	p	S87R	1	.	.	259	261	CGT	620	622	CGT	207;208;209	C;G,A;T	199;200,1;199	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5260	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2893	180.2	1	SNP	p	R87I	0	.	.	259	261	CGT	620	622	CGT	207;208;209	C;G,A;T	199;200,1;199	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5260	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2893	180.2	1	SNP	p	R87W	0	.	.	259	261	CGT	620	622	CGT	207;208;209	C;G,A;T	199;200,1;199	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5260	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2893	180.2	1	SNP	p	S88P	0	.	.	262	264	TCC	623	625	TCC	208;205;205	T;C;C	200;199;198	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4366	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2426	177.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1434	1436	GGC	218;216;217	G;G,T;C	206;205,1;204	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2506	168.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1252	1254	GCC	232;237;237	G;C,T;C	223;223,1;226	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2506	168.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1255	1257	ATG	237;237;237	A;T;G	225;225;222	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2506	168.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1267	1269	ACC	231;232;235	A;C;C	221;225;224	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2506	168.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1267	1269	ACC	231;232;235	A;C;C	221;225;224	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2506	168.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1768	1770	ACC	241;244;243	A,G;C;C	227,1;233;232	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2506	168.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1822	1824	GCG	229;228;228	G;C;G	208;211;213	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2506	168.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1822	1824	GCG	229;228;228	G;C;G	208;211;213	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2506	168.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1945	1947	GGT	191;188;188	G;G;T,C	180;176;175,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2506	168.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1954	1956	AGC	180;175;170	A,G;G;C	168,1;166;157	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4260	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2506	168.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1972	1974	CCG	159;161;160	C,G;C,G;G	120,8;122,1;120	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5804	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3182	180.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1670	1672	CCG	215;217;221	C;C;G	201;206;202	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2154	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1730	123.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	517	517	C	162	C	156	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2940	porB1b	1038	1038	99.81	porB1b.l6.c17.ctg.1	1644	176.9	0	.	p	.	0	G210R	NONSYN	628	630	GGA	956	958	AGA	246;246;243	A;G;A	231;233;230	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2940	porB1b	1038	1038	99.81	porB1b.l6.c17.ctg.1	1644	176.9	0	.	p	.	0	S217G	NONSYN	649	651	AGT	977	979	GGT	237;238;237	G;G;T	225;228;226	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2940	porB1b	1038	1038	99.81	porB1b.l6.c17.ctg.1	1644	176.9	1	SNP	p	G120K	1	.	.	358	360	AAG	686	688	AAG	246;246;245	A;A;G	233;236;233	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2940	porB1b	1038	1038	99.81	porB1b.l6.c17.ctg.1	1644	176.9	1	SNP	p	N121D	0	.	.	361	363	AAC	689	691	AAC	246;247;247	A;A;C	237;238;238	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2940	porB1b	1038	1038	99.81	porB1b.l6.c17.ctg.1	1644	176.9	1	SNP	p	A121N	1	.	.	361	363	AAC	689	691	AAC	246;247;247	A;A;C	237;238;238	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11166	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4750	232.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1178	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	930	125.2	1	SNP	p	V57M	1	.	.	169	171	ATG	500	502	ATG	242;242;244	A;T;G	228;227;231	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
